Loading

Commentary Open Access
Volume 1 | Issue 1 | DOI: https://doi.org/10.46439/Oncology.1.003

Modulating the immunotolerant tumor microenvironment to enhance irreversible electroporation ablation therapy

  • 1Cancer Research, Saskatchewan Cancer Agency, Saskatoon, Saskatchewan, Canada
  • 2Department of Oncology, College of Medicine, University of Saskatchewan, Saskatoon, Saskatchewan, Canada
+ Affiliations - Affiliations

Corresponding Author

Jim Xiang, jim.xiang@usask.ca

Received Date: February 26, 2024

Accepted Date: March 04, 2024

Keywords

Irreversible electroporation, Tumor microenvironment, Toll-like receptor agonist, PD1 blockade, Cancer immunotherapy

Author Information X